These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


308 related items for PubMed ID: 2695657

  • 21. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kawaguchi H, Shimizu Y, Matsumiya H, Saito A, Terai T, Inoue H, Nakadate T, Ito C, Yosida T, Tanno Y, Ohno I, Nishioka K, Arakawa M, Igarashi K, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Touyama M.
    Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
    [Abstract] [Full Text] [Related]

  • 22. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2007)].
    Goto H, Iwasaki M.
    Jpn J Antibiot; 2015 Feb; 68(1):1-18. PubMed ID: 25980050
    [Abstract] [Full Text] [Related]

  • 23. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H, Watanabe K, Kosakai N, Hayashi Y, Oguri T, Saito A, Shinohara M, Matsumiya H, Ueda K, Ida S.
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [Abstract] [Full Text] [Related]

  • 24. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)].
    Shimada K, Nakano K, Igari J, Oguri T, Ikemoto H, Mori T, Yokouchi H, Yamamoto M, Inoue H, Nakadate T, Suwabe A, Okada S, Ashino Y, Gejyo F, Okada M, Aoki N, Kitamura N, Suzuki Y, Karasawa Y, Nakata K, Nakatani T, Inagawa H, Kudo K, Kobayashi N, Tanaka T, Kobayashi H, Goto H, Kawai S, Takeda H, Sumitomo M, Matsushima T, Niki Y, Kohno S, Miyazaki Y, Yanagihara K, Hirakata Y, Matsuda J, Nasu M, Hiramatsu K, Suga M, Tosaka M.
    Jpn J Antibiot; 2004 Jun; 57(3):213-45. PubMed ID: 15376784
    [Abstract] [Full Text] [Related]

  • 25. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2006)].
    Goto H, Takeda H, Kawai S, Suwabe A, Watanabe S, Okazaki M, Ashino Y, Shimada K, Aoki N, Sato T, Honma Y, Mori T, Kudo K, Sugiyama H, Kondo S, Tanaka T, Kido K, Yoshimura K, Oguri T, Yamamoto M, Nakamori Y, Inoue H, Yamauchi K, Sumitomo M, Endo S, Nakadate T, Oka M, Kobashi Y, Saita N, Yanagihara K, Kondou A, Matsuda J, Nakano M, Kohno S, Oikawa S.
    Jpn J Antibiot; 2013 Dec; 66(6):331-55. PubMed ID: 24649798
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Susceptibility of bacteria isolated from the patients with lower respiratory tract infections to antibiotics (1984)].
    Ikemoto H, Watanabe K, Kosakai N, Hayashi Y, Oguri T, Saito A, Shinohara M, Matsumiya H, Ueda K, Terai T.
    Jpn J Antibiot; 1987 Jan; 40(1):91-116. PubMed ID: 3586339
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Studies on respiratory infections in primary care clinic (II). Distribution and antibiotic sensitivity to 45 agents of bacteria isolated from patients with respiratory infections visiting a doctor in private practice].
    Watanabe A, Oizumi K, Motomiya M, Sato T, Shoji M.
    Kansenshogaku Zasshi; 1990 Jan; 64(1):66-75. PubMed ID: 2335751
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The antimicrobial activity of fluoroquinolone agents against pathogenic organisms in respiratory tract infections and its clinical effect].
    Akiyama M, Takahashi A, Nagatake T, Yamashita H, Yoshida T, Rikitomi N, Ohishi K, Tanaka H, Morito T, Utsunomiya Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1174-81. PubMed ID: 2176251
    [Abstract] [Full Text] [Related]

  • 34. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A, Yamaguchi K, Shigeno Y, Kohno S, Shigeno H, Kusano N, Dotsu Y, Hara K.
    Drugs; 1986 Sep; 31 Suppl 3():87-92. PubMed ID: 3488201
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
    Flamm RK, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.